Robert Heelan

EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib

Proceedings of the National Academy of Sciences of the United States of America · 2004 · 3,586 citations

KRAS mutations and primary resistance of lung adenocarcinomas to gefitinib or erlotinib

PLoS Medicine · 2005 · 1,276 citations